Scrip
Antibodies emerge as key focus for Kyowa Kirin
05 June 2009
Ian Haydock
Kyowa Hakko Kirin (KHK) is applying the technologies brought together by the merger of Kyowa Hakko and Kirin Pharma to an expanding pipeline of antibody products.
The hope was that the merger, completed last October, would enable faster antigen acquisition and candidate screening, speeding up...
Please Login to read the full article.
05 June 2009
Ian Haydock
The hope was that the merger, completed last October, would enable faster antigen acquisition and candidate screening, speeding up...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
